VERDICT II, PROFILE II— 510(k) K031032

Name: FDA 510(k) clearance K031032
Creator: U.S. Food and Drug Administration
Published: 2003-07-14

Substantially Equivalent

Medtox Diagnostics, Inc.

FDA 510(k) clearance K031032 for VERDICT II, PROFILE II, Substantially Equivalent on 2003-07-14. Applicant: Medtox Diagnostics, Inc.. Device class: 2.

Clearance details

Applicant: Medtox Diagnostics, Inc.
Product code: Code DJG
Device class: Class 2
Regulation: 21 CFR 862.3650
Advisory panel: Clinical Toxicology
Date received: 2003-04-01
Decision date: 2003-07-14
Decision: Substantially Equivalent
Clearance type: Special
Location: Burlington, NC, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code DJG

view all

K252684 — Labcorp Fentanyl Urine Visual Test2026-01-29
K250741 — Evidence MultiSTAT DOA Urine MultiPlex2026-01-23
K253082 — LZI Buprenorphine II Enzyme Immunoassay2026-01-16
K252520 — SEFRIA Hydrocodone Oral Fluid2025-09-11
K251972 — Healgen® AccuFluor Fentanyl Fluorescence Immunoassay (FIA)Test Kit - Qualitative +1 more2025-08-15

More clearances from Medtox Diagnostics, Inc.

view all

K100951 — MEDTOX BUPRENORPHINE TEST2010-10-18
K100023 — PROFILE-V MEDTOXSCAN DRUGS OF ABUSE TEST SYSTEM AND 12 DRUGS TEST SYSTEM2010-04-05
K091454 — PROFILE-V MEDTOXSCAN DRUGS OF ABUSE TEST SYSTEM2009-07-24
K080635 — MEDTOXSCAN2009-02-13
K060351 — MEDTOX OXYCODONE2006-05-12

Data sourced from openFDA. This site is unofficial and independent of the FDA.